The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry.

The largest deal of the week is Humana’s acquisition of the remaining stake in Kindred at Home, valued at $5.7 billion, including debt, from TPG Capital and Welsh, Carson, Anderson & Stowe. The three companies bought Kindred together in 2017 deal valued at $4.1 billion. Including Humana’s initial investment in 2017, the company has paid $7.1 billion overall for Kindred at Home.

Kindred at Home employs approximately 43,000 caregivers providing home health, hospice, and community care services to over 550,000 patients annually. Kindred at Home has locations in 40 states, providing extensive geographic coverage with approximately 65 percent overlap with Humana’s individual Medicare Advantage membership. As part of the transaction, Kindred at Home’s home health operations will be integrated into Humana’s Home Solutions business, Centerwell. The acquisition is expected to close in Q3:21.

To subscribe to our Health Care M&A deals chart and more, visit our membership is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to developments in all the key segments of the health care service and technology markets.

Pfizer Inc.Amplyx Pharmaceuticals, Inc.N/A
HolmuskOtsuka Health SolutionsN/A
Paya Holdings Inc.Paragon Payments SolutionsN/A
Home Health Care & Hospice  
Humana Inc.Kindred at Home$5,700,000,000
Encompass Health Corp.Frontier Home Health and Hospice assetsN/A
Valeo Home Health & HospiceHearts for Hospice & Home HealthN/A
LHC Group, Texas Health Resources, & Methodist Health SystemRegent Home HealthN/A
Laboratories, MRI and Dialysis  
DispatchHealthProfessional Portable X-RayN/A
The Carlyle Group LPUnchained Labs$435,000,000
Castle Biosciences, Inc.Myriad myPath Melanoma, LLC, Laboratory$32,500,000
Augustus Labs LLCEvergreen-Sheridan LaboratoriesN/A
Arcline Investment ManagementPolypeptide Therapeutic Solutions, S.L.N/A
Medical Devices  
DJO, LLCMedShape, Inc.N/A
Physician Medical Groups  
U.S. Oral Surgery ManagementOral and Maxillofacial Surgery AssociatesN/A
Northwest Medical Specialties, PLLCOsborn Cancer CareN/A
Bryan Physician NetworkThe Surgery Group of Grand IslandN/A
Hunter Street Partners & Healy Capital PartnersKirkpatrick Dental GroupN/A
Eye Health AmericaThe Eye Care CenterN/A
Other Services  
dMed GlobalClinipace IncorporatedN/A